Scan study for prostate cancer after PSA comes back
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This study follows people with prostate cancer whose PSA blood test has risen again after standard treatment. It uses an approved PET scan tracer to look for cancer spread, which may help doctors understand how the disease is progressing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You previously had treatment for prostate cancer (surgery or radiation)
- Your PSA blood test is at least 0.50
- Your testosterone level is above 100
- You are 18 years or older and can sign informed consent
- You will use highly effective birth control (or abstain from heterosexual sex) around study visits
- Your CT (or MRI if needed) should not show cancer in soft tissues outside lymph nodes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a special PET/CT scan (using 18F-DCFPyL) helps evaluate prostate cancer that is either high-risk at diagnosis or has come back based on PSA blood tests. It may help your care team better stage (map) the cancer and guide next steps.
This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.
This trial tests a new imaging drug, 18F-Florastamin, to see if it can better detect prostate cancer that has come back after treatment. You may qualify if you have signs of recurrence and are willing to have a biopsy or additional therapy.
This trial uses special PET imaging to see where progressive prostate cancer is in the body—one tracer to look at general sugar use and one designed to detect testosterone-related activity. It may help doctors better map cancer spread so future treatment planning can be more targeted.
This study uses a PET/CT scan to learn how and why prostate cancer becomes resistant to treatment. It may help researchers better match future therapy choices for people whose prostate cancer is progressing.
This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.